F. Štětka

发表

Do the presence and amount of dysfunctional but viable myocardium affect the perioperative outcome of coronary artery bypass graft surgery?

J. Meluzin, L. Špinarová, M. Frélich, 1999, International journal of cardiology.

Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts.

P. Grayburn, M. Brickner, J. Meluzin, 1995, The American journal of cardiology.

Comparison of Acoustic Densitometry and Dobutamine Echocardiography for an Assessment of Myocardial Viability

J. Vespalec, J. Meluzin, R. Panovský, 2005, Echocardiography.

Prognostic importance of the quantification of myocardial viability in revascularized patients with coronary artery disease and moderate-to-severe left ventricular dysfunction.

J. Meluzin, L. Špinarová, R. Panovský, 2003, International journal of cardiology.

Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability

J. Krejčí, J. Toman, J. Meluzin, 2003, European journal of heart failure.

Coronary artery bypass grafting in patients with left ventricular ejection fraction of 30% or less.

J. Nečas, J. Meluzin, H. Bedanova, 2001, Bratislavske lekarske listy.

Prognostic value of the amount of dysfunctional but viablemyocardium in revascularized patients with coronary arterydisease and left ventricular dysfunction

R. Štípal, J. Meluzin, L. Špinarová, 1999 .

Effects of Nifedipine and Diltiazem on Myocardial Ischemia in Patients with Severe Stable Angina Pectoris Treated with Nitrates and β-Blockers

P. Šimek, J. Meluzin, F. Štětka, 1992, Journal of cardiovascular pharmacology.

Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study.

R. Štípal, J. Meluzin, L. Špinarová, 1998, Journal of the American College of Cardiology.

[The programme of managed ambulatory rehabilitation for patients after heart valve defect surgery].

F. Štětka, Š. Chaloupková, R. Vysoký, 2009, Vnitrni lekarstvi.